BUYER POOL ANALYSIS
Selling a Home Health to Strategic / Industry buyers
Industry operators, larger competitors, and corporate buyers acquiring for synergies, geographic expansion, or capability fill. Typically pays a premium for clear strategic fit but discounts for integration cost and overlap.
Quick answers
- What multiple does this buyer pool pay?
- Median EV/EBITDA 7.5x across 62 disclosed deals (P25: 4.7x, P75: 12.32x). Median EV/Revenue 1x across 88 deals. Median deal value: $22.35M.
- How many disclosed transactions?
- 90 deals total (90 from 2018+), filtered to Strategic / Industry acquirers of home health businesses.
- Most active buyers
- Nova Leap Health Corp. (17) · Addus HomeCare Corporation (10) · Aveanna Healthcare Holdings, Inc. (6) · LHC Group, Inc. (4) · Encompass Health Corp. (4) · Amedisys, Inc. (3)
Recent disclosed deals
Strategic / Industry acquisitions of home health businesses with named target, named acquirer, and disclosed financials.
| Year | Target | Acquirer | EV | EV/EBITDA | EV/Rev |
|---|---|---|---|---|---|
| 2026 | Amedisys Divested Assets (107 locations) | BrightSpring Health Services | $239.0M | 8.0x | 1.33x |
| 2025 | Amedisys Agencies (TN, GA, AL) | The Pennant Group, Inc. | $147.2M | — | 0.80x |
| 2025 | Amedisys Inc. | UnitedHealth Group (Optum) | $3300.0M | 11.8x | 1.50x |
| 2025 | Amedisys' WV Locations | BrightSpring Health Services , Inc. | $24.3M | 6.7x | 0.60x |
| 2025 | Amedisys/UnitedHealth Divested Assets (54 locations) | The Pennant Group | $146.5M | 9.8x | 1.47x |
| 2025 | CBI Home Health | Extendicare Inc. | $408.4M | 9.2x | 1.19x |
What this buyer pool prices for
Strategic buyers — operators in adjacent geographies, larger competitors, or corporate consolidators — price for synergies and capability fill. They tend to discount integration cost and overlap risk but pay above market when there's clear strategic fit (key customer relationship, license, geography, technician/professional team). Multiples are competitive with PE for fee-viable deals; below PE for sub-scale acquisitions.
Methodology note
Multiples shown are computed from disclosed M&A transactions in the ExitValue.ai database, filtered to home health businesses acquired by strategic / industry buyers. EV/EBITDA outliers outside the [0.5x, 60x] band and EV/Revenue outliers outside [0.05x, 25x] are excluded from medians. Where available, post-2018 transactions are weighted; otherwise the all-time sample is used. Deal counts shown reflect deals with disclosed financials only — total transaction count for this buyer pool is typically 2-3x larger. Full methodology
What's your home health worth to strategic / industry?
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Engine-grounded estimate. Comparable strategic / industry deals on the full results page.